• CCR5-Positive Extracellular Vesicles Drive RA Joint Damage

  2026-06-29

  This study reveals that CCR5-containing extracellular vesicles (EVs) from synovial fibroblasts promote cartilage and bone damage in rheumatoid arthritis (RA) by amplifying joint inflammation. Blockade of CCR5, including via encapsulated Maraviroc, attenuates these pathogenic effects, highlighting CCR5 as a promising therapeutic target for RA intervention.

• Hydrocortisone for Advanced Inflammation & EMT Research Work

  2026-06-29

  Hydrocortisone stands as the gold-standard glucocorticoid hormone for dissecting anti-inflammatory pathways, barrier protection, and epithelial-to-mesenchymal transition (EMT) in both basic and translational research. This guide delivers validated protocols, troubleshooting insights, and evidence-driven applications—empowering labs to maximize rigor in inflammation model research, stress response mechanism studies, and metastatic cancer assays.

• HBTU (A7023): Precision Peptide Bond Formation & Benchmarks

  2026-06-28

  HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is a racemization-resistant coupling reagent widely used in peptide bond formation. It is valued for its mild activation, high yield, and compatibility with solid phase peptide synthesis. This article details its mechanism, evidence base, and integration into advanced peptide therapeutic workflows.

• Eicosapentaenoic Acid: Immunomodulation and Cardiovascular S

  2026-06-27

  Explore the advanced immunomodulatory and cardiovascular research applications of Eicosapentaenoic Acid (EPA), an omega-3 fatty acid. This article delivers a fresh perspective on EPA’s mechanistic roles, practical protocol insights, and cross-domain implications, grounded in recent breakthroughs.

• AIBP-LRP2–HDL Axis Restricts CXCR4+ Capillary Expansion in I

  2026-06-26

  This study elucidates a two-phase mechanism by which AIBP-LRP2–mediated HDL uptake curtails the expansion of CXCR4+ stemlike capillary endothelial cells, thereby constraining collateral vessel formation in ischemic muscle. The findings clarify how lipid signaling influences vascular remodeling and suggest new therapeutic strategies for enhancing collateral circulation in peripheral artery disease.

• Murine RNase Inhibitor: Oxidation-Resistant RNA Protection

  2026-06-26

  Murine RNase Inhibitor is a recombinant protein providing robust, oxidation-resistant inhibition of pancreatic-type RNases, ensuring high-fidelity RNA degradation prevention in molecular biology. Its superior stability enables reliable use in workflows such as real-time RT-PCR and cDNA synthesis, outperforming traditional inhibitors in low DTT environments.

• SCH772984 HCl: Advanced Workflows for ERK1/2 Inhibition

  2026-06-25

  SCH772984 HCl stands out as a highly potent ERK1/2 inhibitor, enabling researchers to dissect MAPK pathway resistance and telomerase regulation in BRAF- and RAS-mutant tumor models. Discover protocol enhancements, troubleshooting insights, and practical bridges to emerging DNA repair research.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Itch in Chronic Dermatiti

  2026-06-25

  This study uncovers how elevated 20-HETE in chronic dermatitis sensitizes TRPV1 channels on MrgprA3+ neurons, causing capsaicin to evoke both pain and itch. These findings clarify the neural mechanisms of sensory switching in chronic itch and highlight new therapeutic targets for pruritus management.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-24

  Oliveira et al. reveal that naturally occurring angiotensin peptides—including Angiotensin III—can enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, implicating a molecular connection between the renin-angiotensin system and viral pathogenesis. These findings highlight potential research directions for both cardiovascular and infectious disease fields.

• LC–MS/MS Elucidates GS-441524 Prodrug Pathways and Pharmacok

  2026-06-23

  This study introduces a novel GS-441524 prodrug (NGP-1) and employs a newly established LC–MS/MS method to reveal its conversion to the active antiviral metabolite in vitro and in vivo. The findings provide foundational insights for optimizing anti-SARS-CoV-2 nucleoside analog development and inform experimental strategies for pharmacokinetic and metabolic research.

• hCG Regulates CXCL10 via Histone Methylation in Human Decidu

  2026-06-23

  This study uncovers how human chorionic gonadotropin (hCG) suppresses CXCL10 expression in human decidual stromal cells through EZH2-mediated H3K27me3 histone methylation. These findings reveal a key epigenetic mechanism modulating maternal immune cell recruitment at the maternal-fetal interface, with implications for immune tolerance and pregnancy success.

• Reserpine (N1867): Technical Guidance for Neuropharmacology

  2026-06-22

  Reserpine is a high-purity, research-use-only compound that supports reproducible workflows in neurotransmitter depletion research and antihypertensive mechanism studies. It should only be used in controlled laboratory settings and is not suitable for diagnostic, clinical, or veterinary applications due to its potent biological activity and strict handling requirements.

• ApexPrep DNA Plasmid Miniprep Kit: Optimizing Molecular Biol

  2026-06-22

  Unlock reproducible, high-purity plasmid DNA extraction for demanding molecular biology workflows with the ApexPrep DNA Plasmid Miniprep Kit. Discover evidence-driven optimizations and troubleshooting strategies that bridge advanced applications—from gene cloning to AML research—with streamlined, robust purification.

• Streptavidin-FITC: Precision Fluorescence for Biotin Detecti

  2026-06-21

  Streptavidin-FITC empowers sensitive, reproducible detection of biotinylated molecules across advanced imaging and flow cytometry workflows. APExBIO’s conjugate delivers robust performance for intracellular trafficking studies, immunohistochemistry, and nucleic acid tracking, with data-driven guidance for protocol optimization and troubleshooting.

• PP2A-Mediated Autophagy Drives Drug Resistance in C. albican

  2026-06-20

  This study establishes that protein phosphatase 2A (PP2A) regulates autophagy-dependent biofilm formation and antifungal drug resistance in Candida albicans. By delineating the molecular link between PP2A-induced ATG protein phosphorylation and biofilm resilience, the paper suggests new avenues for targeting persistent fungal infections.

14383 records 1/959 page Next 12345 下5页 Last page